Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F1000Research

Showing results (1081-1090 of 7,354) with videos related to

Pageof 736
Sort By:
F1000Research|March 21, 2022
Experimental-analytical approach to assessing mechanosensitive cartilage blood marker kinetics in healthy adults: dose-response relationship and interrelationship of nine candidate markersSimon Herger, Werner Vach, Anna-Maria Liphardt, et al.
F1000Research|March 15, 2022
Contribution of BCR-ABL molecular variants and leukemic stem cells in response and resistance to tyrosine kinase inhibitors: a reviewMohammad Al Hamad
F1000Research|March 8, 2022
[Online harassment in Japan: Dissecting the targeting of a female journalist]Aki Tonami, Mitsuo Yoshida, Yukie Sano
F1000Research|April 8, 2022
Supplementary data on virus-like particles in the brainstem of Parkinson's disease patients and controlsRobert R Dourmashkin, Peter Locker, Sherman A McCall, et al.
F1000Research|June 6, 2019
2019 ISCB Innovator Award recognizes William Stafford NobleDiane Kovats, Ron Shamir, Christiana Fogg
F1000Research|October 12, 2019
Prefrontal cortex and cognitive control: new insights from human electrophysiologyAlik S Widge, Sarah R Heilbronner, Benjamin Y Hayden
F1000Research|October 12, 2019
Topoisomerases and cancer chemotherapy: recent advances and unanswered questionsMary-Ann Bjornsti, Scott H Kaufmann
F1000Research|May 14, 2019
Dietary patterns and their association with the components of metabolic syndrome: A cross-sectional study of adults from northeast ThailandPornpimon Chupanit, Benja Muktabhant, Frank Peter Schelp
F1000Research|May 10, 2019
FDTool: a Python application to mine for functional dependencies and candidate keys in tabular dataMatt Buranosky, Elmar Stellnberger, Emily Pfaff, et al.
F1000Research|May 10, 2019
RANKL is a therapeutic target of bone destruction in rheumatoid arthritisSakae Tanaka
Pageof 736

Showing results (1081-1090 of 7,354) with videos related to

Sort By:
Pageof 736
F1000Research|March 21, 2022
Experimental-analytical approach to assessing mechanosensitive cartilage blood marker kinetics in healthy adults: dose-response relationship and interrelationship of nine candidate markersSimon Herger, Werner Vach, Anna-Maria Liphardt, et al.
F1000Research|March 15, 2022
Contribution of BCR-ABL molecular variants and leukemic stem cells in response and resistance to tyrosine kinase inhibitors: a reviewMohammad Al Hamad
F1000Research|March 8, 2022
[Online harassment in Japan: Dissecting the targeting of a female journalist]Aki Tonami, Mitsuo Yoshida, Yukie Sano
F1000Research|April 8, 2022
Supplementary data on virus-like particles in the brainstem of Parkinson's disease patients and controlsRobert R Dourmashkin, Peter Locker, Sherman A McCall, et al.
F1000Research|June 6, 2019
2019 ISCB Innovator Award recognizes William Stafford NobleDiane Kovats, Ron Shamir, Christiana Fogg
F1000Research|October 12, 2019
Prefrontal cortex and cognitive control: new insights from human electrophysiologyAlik S Widge, Sarah R Heilbronner, Benjamin Y Hayden
F1000Research|October 12, 2019
Topoisomerases and cancer chemotherapy: recent advances and unanswered questionsMary-Ann Bjornsti, Scott H Kaufmann
F1000Research|May 14, 2019
Dietary patterns and their association with the components of metabolic syndrome: A cross-sectional study of adults from northeast ThailandPornpimon Chupanit, Benja Muktabhant, Frank Peter Schelp
F1000Research|May 10, 2019
FDTool: a Python application to mine for functional dependencies and candidate keys in tabular dataMatt Buranosky, Elmar Stellnberger, Emily Pfaff, et al.
F1000Research|May 10, 2019
RANKL is a therapeutic target of bone destruction in rheumatoid arthritisSakae Tanaka
Pageof 736